Experience36+ Years
LevelLeadership
Career Timeline
- Alnylam PharmaceuticalsCurrentJul 2019–Present· 7 yrs 2 mos
- Group Chief Financial OfficerCurrentJul 2019–Present
- CervoMedCurrentApr 2018–Present· 8 yrs 5 mos
- Board of DirectorsCurrentApr 2018–Present
- Jul 2020–Mar 2024· 3 yrs 8 mos
- Board of DirectorsJul 2020–Mar 2024
- 2018–Apr 2019· 1 yr 3 mos
- Group Chief Financial Officer2018–Apr 2019
- Jul 2003–Dec 2017· 14 yrs 5 mos
- Chief Financial Officer and Executive Director2015–Dec 2017
- Senior Vice President, Investor RelationsJun 2014–Dec 2014
- SVP, Rare Disease BU HeadMay 2013–May 2014
- SVP & GM The Americas and Asia Pacific Commercial Operations Rare Disease BUJul 2010–Apr 2013
- Vice President Finance Rare Disease BUOct 2007–Jun 2010
- Vice President, Finance2005–Sep 2007
- Director Finance, US CommercialJul 2003–Dec 2004
- Sep 1998–Jul 2003· 4 yrs 10 mos
- Manager, Financial PlanningSep 1998–Jul 2003
- Jul 1996–Sep 1998· 2 yrs 2 mos
- Financial Management Development ProgramJul 1996–Sep 1998
- May 1990–May 1994· 4 yrs
- Supply Officer, USS Peoria LST-1183May 1990–May 1994
Education
MBA
Finance
Indiana University - Kelley School of BusinessBA
Economics
Duke UniversityExecutive Relationship Map
Reports To
Jeff Poulton
Vice Chair & President
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer
Skills & Expertise
CommercializationLeadershipFinancial AnalysisFinancial ModelingMergers & AcquisitionsFinanceCertified Management Accountant (CMA)StrategyCross-functional Team LeadershipCompetitive AnalysisSarbanes-Oxley ActFinancial PlanningStrategic Financial PlanningStart-upsMergersManagerial FinancePharmaceutical IndustryLifesciencesForecastingBiotechnology